Leidos Holdings, Inc. (LDOS)

Leidos Holdings, Inc. stock has been influenced by concerns regarding a potential U.S. government shutdown in October 2025. In September 2025, management raised its 2025 guidance for revenue, margins, and EPS following strong second-quarter results. August 2025 saw the company reporting robust Q2 2025 results, showcasing revenue growth and strong operating cash flow. In May 2025, Leidos announced its Q1 fiscal 2025 results, reporting revenue and EPS growth, but Baird downgraded the stock to "Neutral." In February 2025, Leidos reported strong Q4 and full-year 2024 results and provided positive guidance for 2025.

Demand for Leidos's products and services is generally stable and not subject to significant seasonality due to its reliance on government contracts. The company benefits from a predictable flow of government orders and strong worldwide weapons demand. Leidos has consistently reported robust demand throughout all segments and increased demand across all customer segments. The company's substantial backlog of $46.3 billion provides revenue visibility for years to come.

Leidos Holdings, Inc. specializes in scientific, engineering, and information technology services and solutions, operating in the defense, aviation, information technology, and biomedical research sectors. The company offers a wide array of services, including integrated systems, digital transformation, and healthcare information management. Leidos is structured into four divisions: Civil, Health, Advanced Solutions, and Defense & Intelligence.

Headquartered in Reston, Virginia, Leidos has a significant global presence with over 400 locations across 30 countries, including substantial operations in the UK & Europe and Australia. The company contracts extensively with U.S. government agencies and select commercial markets.

Leidos generally maintains a positive brand reputation, with a consensus rating of "Moderate Buy" among financial analysts. The company is recognized for its high standards of integrity and ethical behavior. However, Leidos faced a negative event when the Chinese Ministry of Commerce placed it on its export control list on March 4, 2025. Leidos has been involved in initiatives that enhance its reputation, such as supporting the Department of Defense's Military & Family Life Counseling (MFLC) Program.

Institutional investors hold a significant portion of Leidos Holdings, Inc. stock, ranging from approximately 59.86% to 79% of the company's shares. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and State Street Corp. The general public holds around 20% to 39.41% of the stock, while insiders own less than 1%.